These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1207364)

  • 1. [Pharmokinetic study of methampicillin in normal subjects and those with chronic renal insufficiency].
    Devulder B; Lemaire P; Plouvier B; Tacquet A
    Lille Med; 1975 Nov; 20(9):788-97. PubMed ID: 1207364
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ampicillin dosage for children depending on the degree of renal failure and body weight. IV].
    Sieniawska M; Wróblewska-Kałuzewska MU; Korniszewska J; Wierzba K
    Pediatr Pol; 1980 Jun; 55(6):691-8. PubMed ID: 7413317
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetics of ampicillin in anephric children without and during hemodialysis and in normal subjects].
    Lares-Asseff I; Jiménez MA; Guzmán A; Zaltman S; Cravioto J
    Bol Med Hosp Infant Mex; 1987 Nov; 44(11):677-84. PubMed ID: 3689559
    [No Abstract]   [Full Text] [Related]  

  • 4. Penetration of ampicillin into brain of rats with chronic renal failure.
    Smithers JL; Nicholls PJ; Maddocks JL
    J Antimicrob Chemother; 1976 Dec; 2(4):385-6. PubMed ID: 1032648
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relationship between plasma ampicillin clearance and endogenous creatinine clearance. III].
    Sieniawska M; Wróblewska-Kałuzewska M; Wierzbowska-Lange B; Wierzba K
    Pediatr Pol; 1980 Jun; 55(6):683-9. PubMed ID: 7413316
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic aspects of thiamphenicol in subjects with normal renal function and in patients with chronic renal insufficiency, with or without haemodialysis.
    Tacquet A; Devulder B; Cuvelier D; Legros J
    Postgrad Med J; 1974 Oct; 50 Suppl 5():36-8. PubMed ID: 4470815
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of amoxycillin and ampicillin in patients with renal failure.
    Ksiazek A; Twardowski Z; Przyborowski L; Majdan M; Sokołowska G; Hopkała H; Solski J; Zbikowska A; Misztal G; Bocheńska-Nowacka E
    Ann Univ Mariae Curie Sklodowska Med; 1983; 38():79-86. PubMed ID: 6600085
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum levels of cephalothin, ampicillin and cloxacillin in children with and without renal failure].
    Sieniawaska M; Wróblewska-Kałuzewska M; Wierzbowska-Lange B; Korniszewska J; Kaźmirowska Z; Suska A; Janecki J
    Pediatr Pol; 1974 Feb; 49(2):133-41. PubMed ID: 4549872
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolic and nutrition care in patients with chronic renal insufficiency and chronic kidney failure].
    Teplan V; Schück O; Marecková O
    Vnitr Lek; 2003 May; 49(5):374-8. PubMed ID: 12908171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Albumin metabolism in chronic renal insufficiency].
    Kozlov VV; Rjabov SI
    Z Gesamte Inn Med; 1981 Nov; 36(22):889-91. PubMed ID: 7342514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peculiar problems of phosphocalcium metabolism in chronic renal insufficiency].
    Drüeke T
    Rev Prat; 1989 Apr; 39(11):954-8. PubMed ID: 2717868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal clearance of hippurate in persons with chronic renal insufficiency].
    Schück O; Spustová V; Dzúrik R; Teplan V; Nádvorníková H; Skibová J
    Vnitr Lek; 1994 Jul; 40(7):407-10. PubMed ID: 8073654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum half-life and renal clearance of 3H peruvoside. Study on normal persons and patients with terminal kidney insufficiency].
    Kramer P; Willms B; Horenkamp J; Scheler F
    Verh Dtsch Ges Kreislaufforsch; 1969; 35():440-4. PubMed ID: 5380625
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of nitrendipine in patients with renal failure: comparison to normal subjects.
    Aronoff GR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S974-6. PubMed ID: 6085387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protracted action of vecuronium in a patient with chronic renal insufficiency treated by dialysis].
    Hackl W; Plainer B; Mauritz W
    Anaesthesist; 1988 Sep; 37(9):598-600. PubMed ID: 2903692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic analysis of D-xylose absorption in normal subjects and in patients with chronic renal failure.
    Craig RM; Murphy P; Gibson TP; Quintanilla A; Chao GC; Cochrane C; Patterson A; Atkinson AJ
    J Lab Clin Med; 1983 Mar; 101(3):496-506. PubMed ID: 6827177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of cefotaxime and metabolites in uremic patients (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Godin M; Humbert G
    Nephrologie; 1982; 3(1):12-8. PubMed ID: 6283411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of chronic renal failure on the D-xylose test in man].
    Dederding JP; Cochet B; Balant L; Favre H; Loizeau E
    Gastroenterol Clin Biol; 1988; 12(6-7):542-7. PubMed ID: 3417081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis for and intestinal metabolism of precursor nitroso compounds in normal subjects and in patients with chronic renal failure.
    Simenhoff ML; Dunn SR; Lele PS
    IARC Sci Publ; 1984; (57):161-70. PubMed ID: 6533003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ceftriaxone in subjects with renal insufficiency.
    Kowalsky SF; Echols RM; Parker MA
    Clin Pharm; 1985; 4(2):177-81. PubMed ID: 3987216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.